Bionano to Present at the 43rd Annual Cowen Healthcare Conference
Bionano Genomics (Nasdaq: BNGO) announced its participation at the 43rd Annual Cowen Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bionano Genomics (Nasdaq: BNGO) announced its participation at the 43rd Annual Cowen Healthcare Conference. Erik Holmlin, Ph.D., the company's president and CEO, will present a corporate overview on March 6th, 2023, at 1:30 pm ET. The presentation will be available via a live webcast accessible on Bionano’s Investors website.
Details
News Market Reaction – BNGO
The recorded move for BNGO in the trading session of this news was +2.36%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that company management will present at the 43rd Annual Cowen Healthcare Conference. Erik Holmlin, Ph.D., Bionano’s president and chief executive officer, is scheduled to present a corporate overview on Monday, March 6th, 2023 at 1:30 pm ET.
A live webcast of the presentation will be available to view on the Events page in the Investors section of Bionano’s website.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Amy Conrad
Juniper Point
+1 (858) 366-3243
amy@juniper-point.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.